Atorvastatin 10 mg daily

DRUG2 trials

Sponsors

Boca Raton Regional Hospital, Suzhou Municipal Hospital of Anhui Province

Conditions

Cerebral Small Vessel DiseaseIschemic White Matter Lesions (WMIL)Saphenous Vein Graft DiseaseVCAM-1Vascular Cell Adhesion Molecule-1

Phase 3

Aggressive Cholesterol Therapy to Inhibit Vein Graft Events After CABG (ACTIVE Trial)

CompletedNCT01528709

Boca Raton Regional HospitalSaphenous Vein Graft Disease

Start: 2012-03-31End: 2017-01-31Updated: 2018-09-07

Unknown Phase

Atorvastatin Mitigates WMH-Related Cognitive Impairment by Reducing VCAM-1

CompletedNCT07128212

Suzhou Municipal Hospital of Anhui ProvinceCerebral Small Vessel Disease, Ischemic White Matter Lesions (WMIL), Vascular Cell Adhesion Molecule-1 +1

Start: 2021-01-01End: 2022-12-31Updated: 2025-08-17

Related Papers

Intensive versus moderate atorvastatin therapy and one-year graft patency after CABG: Rationale and design of the ACTIVE (Aggressive Cholesterol Therapy to Inhibit Vein Graft Events) randomized controlled trial (NCT01528709).

2017-06-108 citations